{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:22:40Z","timestamp":1775182960071,"version":"3.50.1"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00134-020-06011-8","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T07:02:44Z","timestamp":1585551764000},"page":"1481-1483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Modified 4T score for heparin-induced thrombocytopenia diagnosis in VA-ECMO patients"],"prefix":"10.1007","volume":"46","author":[{"name":"the HIT-ECMO Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Renou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Neuschwander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Kimmoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Pirracchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"6011_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-016-4312-9","volume":"42","author":"D Abrams","year":"2016","unstructured":"Abrams D, Baldwin MR, Champion M, Agerstrand C, Eisenberger A, Bacchetta M, Brodie D (2016) Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study. Intensive Care Med 42:844\u2013852. https:\/\/doi.org\/10.1007\/s00134-016-4312-9","journal-title":"Intensive Care Med"},{"key":"6011_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11239-017-1494-0","volume":"44","author":"J Bain","year":"2017","unstructured":"Bain J, Flannery AH, Flynn J, Dager W (2017) Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations. J Thromb Thrombolysis 44:76\u201387. https:\/\/doi.org\/10.1007\/s11239-017-1494-0","journal-title":"J Thromb Thrombolysis"},{"key":"6011_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s00134-018-5346-y","volume":"44","author":"A Kimmoun","year":"2018","unstructured":"Kimmoun A, Oulehri W, Sonneville R, Grisot PH, Zogheib E, Amour J, Aissaoui N, Megarbane B, Mongardon N, Renou A, Schmidt M, Besnier E, Delmas C, Dessertaine G, Guidon C, Nesseler N, Labro G, Rozec B, Pierrot M, Helms J, Bougon D, Chardonnal L, Medard A, Ouattara A, Girerd N, Lamiral Z, Borie M, Ajzenberg N, Levy B (2018) Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study. Intensive Care Med 44:1460\u20131469. https:\/\/doi.org\/10.1007\/s00134-018-5346-y","journal-title":"Intensive Care Med"},{"key":"6011_CR4","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","volume":"120","author":"A Cuker","year":"2012","unstructured":"Cuker A, Gimotty PA, Crowther MA, Warkentin TE (2012) Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 120:4160\u20134167. https:\/\/doi.org\/10.1182\/blood-2012-07-443051","journal-title":"Blood"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-06011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-020-06011-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-020-06011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T23:06:15Z","timestamp":1617059175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-020-06011-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["6011"],"URL":"https:\/\/doi.org\/10.1007\/s00134-020-06011-8","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"11 March 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Brodie reports receiving research support from ALung Technologies and prior, current or future expected participation in Medical Advisory Boards for ALung Technologies, Baxter, BREETHE, Hemovent, Xenios and Novalung. Dr Kimmoun received speaker\u2019s honoraria from Baxter, Aspen, MSD, and Gilead. The other authors declare no conflict of interest related to the submitted paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}